Cita APA

Shi, F., Zhang, J., liu, H., Wu, L., Jiang, H., Wu, Q., . . . Wu, H. (2018). Correction: The dual PI3K/mTOR inhibitor dactolisib elicits anti-tumor activity in vitro and in vivo. Oncotarget.

Chicago Style Citation

Shi, Fei, Jinying Zhang, Hongyu liu, Liangliang Wu, Hongyu Jiang, Qiyan Wu, Tianyi Liu, Meiqing Lou, i Hao Wu. "Correction: The Dual PI3K/mTOR Inhibitor Dactolisib Elicits Anti-tumor Activity in Vitro and in Vivo." Oncotarget 2018.

Cita MLA

Shi, Fei, et al. "Correction: The Dual PI3K/mTOR Inhibitor Dactolisib Elicits Anti-tumor Activity in Vitro and in Vivo." Oncotarget 2018.